Proton and Intensity-Modulated Radiation Therapy for Oropharyngeal Cancer Show Similar Late Effects, QoL, Gastrostomy Dependence, Swallow Function, Local Control and OS By Ogkologos - April 2, 2026 180 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TORPEdO study Source RELATED ARTICLESMORE FROM AUTHOR How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence Aiming to Improve Cancer Prevention, ESMO Calls for Strong Policy Measures to Fight the Tobacco Epidemic in Feedback on the EU Tobacco Products and... MOST POPULAR FDA Granted Accelerated Approval to Belantamab Mafodotin-blmf for Multiple Myeloma August 14, 2020 On legacy giving: “It allows me to give something more meaningful... October 13, 2021 FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma February 28, 2024 5-Yr-Old Has Cutest Celebration With Big Brother After Being Declared Cancer-Free. May 21, 2019 Load more HOT NEWS Nivolumab Added to Cisplatin and Radiotherapy Improves DFS in Patients with... FDA Grants Traditional Approval to Selpercatinib for RET Fusion-positive Thyroid Cancer New Approach May Help People with Cancer Better Manage Depression, Pain,... Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses
